[HTML][HTML] In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug Interactions
M Karlgren, G Ahlin, CAS Bergström, R Svensson… - Pharmaceutical …, 2012 - Springer
Purpose To establish in vitro and in silico models that predict clinical drug–drug interactions
(DDIs) with the OATP1B1 (SLCO1B1) transporter. Methods The inhibitory effect of 146 drugs …
(DDIs) with the OATP1B1 (SLCO1B1) transporter. Methods The inhibitory effect of 146 drugs …
[HTML][HTML] In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug-Drug Interactions
M Karlgren, G Ahlin, CAS Bergström… - Pharmaceutical …, 2012 - diva-portal.org
To establish in vitro and in silico models that predict clinical drug-drug interactions (DDIs)
with the OATP1B1 (SLCO1B1) transporter. The inhibitory effect of 146 drugs and drug-like …
with the OATP1B1 (SLCO1B1) transporter. The inhibitory effect of 146 drugs and drug-like …
[PDF][PDF] In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug Interactions
M Karlgren, G Ahlin, CAS Bergström, R Svensson… - Pharm …, 2012 - researchgate.net
In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug
Interactions Page 1 RESEARCH PAPER In Vitro and In Silico Strategies to Identify OATP1B1 …
Interactions Page 1 RESEARCH PAPER In Vitro and In Silico Strategies to Identify OATP1B1 …
[PDF][PDF] In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug Interactions
M Karlgren, G Ahlin, CAS Bergström, R Svensson… - Pharm Res, 2012 - core.ac.uk
In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug
Interactions Page 1 RESEARCH PAPER In Vitro and In Silico Strategies to Identify OATP1B1 …
Interactions Page 1 RESEARCH PAPER In Vitro and In Silico Strategies to Identify OATP1B1 …
In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug Interactions
M Karlgren, G Ahlin, CAS Bergström… - Pharmaceutical …, 2012 - infona.pl
Purpose To establish in vitro and in silico models that predict clinical drug–drug interactions
(DDIs) with the OATP1B1 (SLCO1B1) transporter. Methods The inhibitory effect of 146 drugs …
(DDIs) with the OATP1B1 (SLCO1B1) transporter. Methods The inhibitory effect of 146 drugs …
In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug-Drug Interactions.
M Karlgren, G Ahlin, C Bergström… - Pharmaceutical …, 2012 - search.ebscohost.com
Purpose: To establish in vitro and in silico models that predict clinical drug-drug interactions
(DDIs) with the OATP1B1 (SLCO1B1) transporter. Methods: The inhibitory effect of 146 …
(DDIs) with the OATP1B1 (SLCO1B1) transporter. Methods: The inhibitory effect of 146 …
[PDF][PDF] In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug Interactions
M Karlgren, G Ahlin, CAS Bergström, R Svensson… - Pharm …, 2012 - cyberleninka.org
In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug
Interactions Page 1 RESEARCH PAPER In Vitro and In Silico Strategies to Identify OATP1B1 …
Interactions Page 1 RESEARCH PAPER In Vitro and In Silico Strategies to Identify OATP1B1 …
In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug-Drug Interactions
M Karlgren, G Ahlin, CAS Bergström… - Pharmaceutical …, 2012 - swepub.kb.se
To establish in vitro and in silico models that predict clinical drug-drug interactions (DDIs)
with the OATP1B1 (SLCO1B1) transporter. The inhibitory effect of 146 drugs and drug-like …
with the OATP1B1 (SLCO1B1) transporter. The inhibitory effect of 146 drugs and drug-like …
[PDF][PDF] In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug Interactions
M Karlgren, G Ahlin, CAS Bergström, R Svensson… - Pharm Res, 2012 - Citeseer
In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug
Interactions Page 1 RESEARCH PAPER In Vitro and In Silico Strategies to Identify OATP1B1 …
Interactions Page 1 RESEARCH PAPER In Vitro and In Silico Strategies to Identify OATP1B1 …
[引用][C] In Vitro and In Silico Strategies to Identify OATP IBI Inhibitors and Predict Clinical Drug―Drug Interactions
M KARLGREN, G AHLIN… - Pharmaceutical …, 2012 - pascal-francis.inist.fr
In Vitro and In Silico Strategies to Identify OATP IBI Inhibitors and Predict Clinical Drug―Drug
Interactions CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
Interactions CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …